Virtu Financial’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-19,103
Closed -$18K 2109
2024
Q1
$18K Buy
+19,103
New +$33.1K ﹤0.01% 1184
2023
Q3
Sell
-1,265
Closed -$6K 2231
2023
Q2
$6K Buy
1,265
+516
+69% +$2.53K ﹤0.01% 1395
2023
Q1
$3K Buy
+749
New +$4.21K ﹤0.01% 1424
2022
Q4
Sell
-676
Closed -$12K 2602
2022
Q3
$12K Sell
676
-744
-52% -$26.1K ﹤0.01% 1503
2022
Q2
$72K Buy
+1,420
New +$106K 0.01% 1016
2022
Q1
Sell
-414
Closed -$71K 2407
2021
Q4
$71K Buy
+414
New +$154K 0.01% 1245
2021
Q3
Sell
-37
Closed -$19K 2229
2021
Q2
$19K Buy
+37
New +$19.9K ﹤0.01% 1413
2019
Q4
$10K Sell
56
-44
-44% -$5.68K ﹤0.01% 1370
2019
Q3
$15K Sell
100
-6
-6% -$799 ﹤0.01% 1316
2019
Q2
$12K Buy
106
+41
+63% +$6.5K ﹤0.01% 1380
2019
Q1
$11K Buy
+65
New +$11.1K ﹤0.01% 1338
2018
Q4
Sell
-71
Closed -$11K 2114
2018
Q3
$11K Buy
+71
New +$29.7K ﹤0.01% 1446
2018
Q1
Sell
-308
Closed -$376K 2824
2017
Q4
$376K Buy
308
+273
+780% +$128K 0.02% 1073
2017
Q3
$6K Buy
+35
New +$5.54K ﹤0.01% 2430

Other funds holding AMPE

Virtu Financial's AMPE Position: Q2 2024 in Review

Virtu Financial sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2024, closing a stake of 19,103 shares — an estimated $18K sold.

Virtu Financial first reported a position in AMPE in Q3 2017 and held it in 14 quarters. The position peaked at $376K in Q4 2017. 6 funds tracked by Wall St. Rank hold AMPE as of Q2 2024.

  • Virtu Financial reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2024 after selling out during the quarter.
  • Virtu Financial sold 19,103 Ampio Pharmaceuticals Inc. shares in Q2 2024, an estimated $18K.
  • Virtu Financial first reported a position in Ampio Pharmaceuticals Inc. in Q3 2017 and held it in 14 quarters.
  • Virtu Financial's Ampio Pharmaceuticals Inc. position peaked at $376K in Q4 2017.
  • 6 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2024.

Based on Virtu Financial's 13F filing for Q2 2024, filed 9 Aug 2024.